Research Article
Adverse Reaction Signals Mining of Vonoprazan: A Pharmacovigilance Study Based on FAERS
Table 5
Top significant signals on the SOC level.
| | SOC | ROR (95% CI) | IC (IC025) |
| | Hepatobiliary disorders | 5.65 (5.14–6.2) | 29.15 (26.54) | | Metabolism and nutrition disorders | 2.78 (2.57–3.02) | 28.12 (25.94) | | Blood and lymphatic system disorders | 2.73 (2.48–3.01) | 28.12 (25.53) | | Investigations | 2.19 (2.05–2.34) | 27.76 (26.00) | | Endocrine disorders | 2.09 (1.79–2.45) | 27.76 (23.76) | | Gastrointestinal disorders | 1.87 (1.77–1.98) | 27.52 (25.99) | | Cardiac disorders | 1.76 (1.63–1.90) | 27.47 (25.43) | | Renal and urinary disorders | 1.73 (1.57–1.91) | 27.47 (24.91) | | Immune system disorders | 1.47 (1.34–1.62) | 27.24 (24.73) | | Respiratory, thoracic and mediastinal disorders | 1.25 (1.16–1.35) | 27.00 (25.07) |
|
|
